title: Are we losing artemisinin combination therapy already?
authors.affiliation: Malaria Antigen Discovery Program, Seattle Biomedical Research Institute and Walter Reed Army Institute of Research, Seattle, WA 98109, USA. pduffy@sbri.org
authors.forename: Patrick E
authors.initials: PE
authors.lastname: Duffy
authors.forename: Carol Hopkins
authors.initials: CH
authors.lastname: Sibley
mesh_terms: D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use*; D004351:Drug Resistance / Q000235:genetics*; D004359:Drug Therapy, Combination; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D015767:Mefloquine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D015767:Mefloquine